Mesterolone treatment of patients with pathospermia

Research output: Contribution to journalArticle

5 Citations (Scopus)


The response to Mesterolone, in doses of 25 mg/day, was examined in 42 pathospermic patients. Treatment lasted for 100 days. The pronounced response to the Mesterolone treatment was observed in hypozoo- and oligozoospermia with low initial fructose content in the ejaculate. Fructose content attained its normal range after the treatment. During the therapeutic period 11 wives became pregnant. The authors conclude that Mesterolone does not influence plasma FSH, LH and testosterone levels, it has only peripheral effects.

Original languageEnglish
Pages (from-to)251-256
Number of pages6
JournalInternational urology and nephrology
Issue number3
Publication statusPublished - Sep 1 1978

ASJC Scopus subject areas

  • Nephrology
  • Urology

Fingerprint Dive into the research topics of 'Mesterolone treatment of patients with pathospermia'. Together they form a unique fingerprint.

  • Cite this